NDC 61919-711

CHLORDIAZEPOXIDE

Chlordiazepoxide

CHLORDIAZEPOXIDE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Direct Rx. The primary component is Chlordiazepoxid.

Product ID61919-711_2f1d49ad-13cc-2a23-e054-00144ff88e88
NDC61919-711
Product TypeHuman Prescription Drug
Proprietary NameCHLORDIAZEPOXIDE
Generic NameChlordiazepoxide
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2016-03-04
Marketing CategoryANDA / ANDA
Application NumberANDA085475
Labeler NameDIRECT RX
Substance NameCHLORDIAZEPOXID
Active Ingredient Strength25 mg/1
Pharm ClassesBenzodiazepine
DEA ScheduleCIV
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 61919-711-20

20 CAPSULE in 1 BOTTLE (61919-711-20)
Marketing Start Date2016-03-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61919-711-20 [61919071120]

CHLORDIAZEPOXIDE CAPSULE
Marketing CategoryANDA
Application NumberANDA085475
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-03-04
Marketing End Date2019-04-04

Drug Details

Pharmacological Class

  • Benzodiazepine [EPC]
  • Benzodiazepines [CS]

NDC Crossover Matching brand name "CHLORDIAZEPOXIDE" or generic name "Chlordiazepoxide"

NDCBrand NameGeneric Name
61919-593CHLORDIAZEPOXIDECHLORDIAZEPOXIDE
61919-711CHLORDIAZEPOXIDECHLORDIAZEPOXIDE

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.